JP3037654B2 - Easy-absorbable folic acid preparation, production method thereof and feed containing the same - Google Patents

Easy-absorbable folic acid preparation, production method thereof and feed containing the same

Info

Publication number
JP3037654B2
JP3037654B2 JP10039582A JP3958298A JP3037654B2 JP 3037654 B2 JP3037654 B2 JP 3037654B2 JP 10039582 A JP10039582 A JP 10039582A JP 3958298 A JP3958298 A JP 3958298A JP 3037654 B2 JP3037654 B2 JP 3037654B2
Authority
JP
Japan
Prior art keywords
folic acid
casein
coprecipitate
folate
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP10039582A
Other languages
Japanese (ja)
Other versions
JPH11221028A (en
Inventor
孝範 荻根
茂雄 羽根
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Federation of Agricultural Cooperative Associations
Original Assignee
National Federation of Agricultural Cooperative Associations
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Federation of Agricultural Cooperative Associations filed Critical National Federation of Agricultural Cooperative Associations
Priority to JP10039582A priority Critical patent/JP3037654B2/en
Publication of JPH11221028A publication Critical patent/JPH11221028A/en
Application granted granted Critical
Publication of JP3037654B2 publication Critical patent/JP3037654B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、易吸収性葉酸製
剤、その製造方法及びそれを含む飼料に関する。本発明
の易吸収性葉酸製剤は、葉酸の安定性及び家畜による葉
酸の吸収性に優れるので、家畜やペットの飼料への配合
剤として有用である。
TECHNICAL FIELD The present invention relates to an easily absorbable folate preparation, a method for producing the same, and a feed containing the same. INDUSTRIAL APPLICABILITY The easily absorbable folate preparation of the present invention is excellent in stability of folic acid and excellent absorption of folic acid by livestock, and thus is useful as a compounding agent for feed of livestock and pets.

【0002】[0002]

【従来の技術】葉酸及びその関連化合物は、ヒト、サ
ル、ヒナの抗貧血性ビタミン、すなわち、酵母エキスや
肝エキス中に存在するヒト、サルの食餌性巨赤芽球性貧
血の予防・治療因子として、また、ヒナやある種の乳酸
菌の成育因子として見出されてきたB群ビタミンの1つ
であり、医薬品、食品、飼料添加物として化学合成した
葉酸が使用されている。
2. Description of the Related Art Folic acid and its related compounds are anti-anemic vitamins of humans, monkeys and chicks, ie, prevention and treatment of dietary megaloblastic anemia of humans and monkeys present in yeast extract and liver extract. It is one of the group B vitamins that has been found as a factor and as a growth factor for chicks and certain lactic acid bacteria. Chemically synthesized folic acid is used as a pharmaceutical, food or feed additive.

【0003】しかし、葉酸は他の栄養成分と比較してそ
の配合量が極めて微量であり、均一に配合するために微
細な結晶粉末として使用されることが多く、光、湿度、
温度及び同時に配合されるミネラル等のたの成分により
化学的変化を受けやすい。また、葉酸は、極めて水に難
溶性のためブタなどでは吸収性が悪く、化学的に安定
で、吸収性の優れた葉酸製剤が望まれている。
[0003] However, the amount of folic acid is extremely small compared to other nutrients, and it is often used as a fine crystalline powder in order to uniformly mix it.
It is susceptible to chemical changes depending on temperature and other components such as minerals incorporated at the same time. Further, folic acid is extremely poorly soluble in water, and therefore has poor absorption in pigs and the like, and a folic acid preparation which is chemically stable and excellent in absorption is desired.

【0004】従来、葉酸を安定化する方法として、融点
の高い油脂等により被覆する方法(特公昭59−768
5号公報)、有機溶媒を使用した「相分離法」によりマ
イクロカプセル化する方法(特開昭53−81387号
公報)、シクロデキストリンにより包接化合物とする方
法(特開昭62−281855号公報)、デキストリ
ン、ゼラチン等で被覆する方法(特開平6−19773
3号公報)等が開示されているが、これらの技術は、安
定性と溶解性の両方を改善するものは少なく、また、有
毒で有害な有機溶媒を使用する方法は、家畜等への安全
性に問題があり、コスト的にも実用性が低い。
Conventionally, as a method of stabilizing folic acid, a method of coating with a high melting point oil or the like (Japanese Patent Publication No. 59-768).
No. 5), a method of microencapsulation by a "phase separation method" using an organic solvent (JP-A-53-81387), and a method of forming an inclusion compound with cyclodextrin (JP-A-62-281855). ), A method of coating with dextrin, gelatin or the like (JP-A-6-19773).
No. 3) is disclosed, but few of these techniques improve both stability and solubility, and the method of using toxic and harmful organic solvents is safe for livestock and the like. There is a problem with the properties, and the cost is not practical.

【0005】[0005]

【発明が解決しようとする課題】本発明の目的は、優れ
た安定性と高い溶解性を有する新規な易吸収性の葉酸製
剤、その製造方法及びそれを含有する飼料を提供するこ
とである。
SUMMARY OF THE INVENTION An object of the present invention is to provide a novel easily absorbable folic acid preparation having excellent stability and high solubility, a method for producing the same, and a feed containing the same.

【0006】[0006]

【課題を解決するための手段】本願発明者等は、葉酸の
バイオアベイラビリティ改善のため鋭意研究した結果、
有毒で有害な有機溶媒等を一切使用しない、安全で新規
な葉酸とカゼインの共沈物の製造方法を見出すととも
に、この共沈物はバイオアベイラビリティが著しく高
く、かつ、安定性の良いものであることを見出し、本発
明を完成した。
Means for Solving the Problems The inventors of the present invention have conducted intensive studies for improving the bioavailability of folic acid,
In addition to finding a safe and novel method for producing folic acid and casein coprecipitate that does not use any toxic and harmful organic solvents, this coprecipitate has remarkably high bioavailability and good stability Thus, the present invention has been completed.

【0007】すなわち、本発明は、葉酸と、カゼイン及
び/又はカゼイン含有物の共沈物を含む葉酸製剤を提供
する。また、本発明は、葉酸と、カゼイン及び/又はカ
ゼイン含有物を少なくとも含むアルカリ性溶液に酸を添
加し、葉酸とカゼインを共沈させる工程を含む、上記本
発明の葉酸製剤の製造方法を提供する。さらに、本発明
は、上記本発明の葉酸製剤を含む飼料を提供する。
That is, the present invention provides a folic acid preparation comprising folic acid and a coprecipitate of casein and / or a casein-containing substance. Further, the present invention provides the method for producing a folate preparation of the present invention, which comprises a step of adding an acid to an alkaline solution containing at least folic acid and casein and / or a casein-containing substance to coprecipitate folic acid and casein. . Further, the present invention provides a feed containing the folic acid preparation of the present invention.

【0008】[0008]

【発明の実施の形態】上記のように、本発明の葉酸製剤
は、葉酸と、カゼイン及び/又はカゼイン含有物の共沈
物を含む。ここで用いられる葉酸としては、通常入手し
得る粉末、結晶又は乾燥前のスラリー状の最終合成品の
いずれでも用いることができ、特に制限はない。また、
カゼイン及び/又はカゼイン含有物は、葉酸と共沈させ
て共沈物とし、それによって葉酸の少なくとも一部、好
ましくは50%以上、さらに好ましくは90%以上、最
も好ましくは全量を非結晶状態に維持するために使用さ
れるが、カゼイン含有物としては、カゼインナトリウ
ム、牛乳、脱脂粉乳、発酵乳、ヨーグルト等が使用でき
る。
As described above, the folate preparation of the present invention contains a coprecipitate of folic acid and casein and / or a casein-containing substance. The folic acid used here can be any of powders, crystals or final synthesized products in the form of a slurry before drying, and is not particularly limited. Also,
The casein and / or casein-containing material is coprecipitated with folic acid to form at least a portion, preferably at least 50%, more preferably at least 90%, and most preferably the entire amount of folic acid in an amorphous state. It is used for maintaining, and as casein-containing substances, sodium caseinate, milk, skim milk powder, fermented milk, yogurt and the like can be used.

【0009】共沈物中の葉酸とカゼイン及び/又はカゼ
イン含有物との比率は特に限定されないが、葉酸があま
りに多すぎると葉酸の分散が不十分となって結晶性の葉
酸が含まれることになり、安定性及び吸収性が低下する
ので好ましくない。従って、葉酸とカゼイン及び/又は
カゼイン含有物との配合比率は、葉酸とカゼインの比率
で、葉酸1重量部に対しカゼインとして1重量部以上、
さらに好ましくは2重量部以上である。一方、葉酸の配
合量の下限については全く制限はないが、葉酸があまり
に少なすぎると必要量の葉酸を投与するために多量の葉
酸製剤を投与することが必要となって不経済であるの
で、通常、葉酸とカゼインの配合比率は、葉酸1重量部
に対してカゼインとして1000重量部以下、好ましく
は200重量部以下である。
The ratio of folic acid to casein and / or casein-containing material in the coprecipitate is not particularly limited. However, if the amount of folic acid is too large, dispersion of folic acid becomes insufficient and crystalline folic acid is contained. It is not preferable because the stability and the absorbability decrease. Therefore, the compounding ratio of folic acid and casein and / or a casein-containing material is 1% by weight or more of casein to 1 part by weight of folic acid in a ratio of folic acid and casein,
It is more preferably at least 2 parts by weight. On the other hand, there is no limitation on the lower limit of the amount of folic acid, but if the amount of folic acid is too small, it is uneconomical to administer a large amount of folic acid preparation to administer the required amount of folic acid, Usually, the mixing ratio of folic acid and casein is not more than 1000 parts by weight, preferably not more than 200 parts by weight, as casein per 1 part by weight of folic acid.

【0010】上記共沈物は、葉酸と、カゼイン及び/又
はカゼイン含有物のアルカリ性溶液に酸を添加し、葉酸
とカゼインを共沈させることにより製造することができ
る。例えば、葉酸とカゼイン及び/又はカゼイン含有物
の1又は2以上の配合物にアルカリ溶液を添加し、pH
を8以上、好ましくは10以上として葉酸とカゼインを
溶解させた後、酸(好ましくは水溶液)を添加し、pH
を5以下、好ましくは4以下にして葉酸とカゼインを共
沈させることにより製造することができる。葉酸とカゼ
イン及び/又はカゼイン含有物のアルカリ性溶液を調製
する方法としては、葉酸とカゼイン及び/又はカゼイン
含有物をそれぞれ個別にアルカリ溶液又は水に溶解又は
分散したものを混合し、アルカリ水溶液を添加してpH
を8以上として葉酸とカゼインを溶解させてもよいし、
また、葉酸とカゼイン及び/又はカゼイン含有物の混合
物にアルカリ水溶液を添加して溶解させてもよい。ま
た、調製したアルカリ性溶液中の葉酸とカゼインの合計
濃度は、特に限定されないが、通常、1〜15重量%程
度である。
The above coprecipitate can be produced by adding an acid to folic acid and an alkaline solution of casein and / or a casein-containing substance to coprecipitate folic acid and casein. For example, an alkaline solution is added to one or more formulations of folic acid and casein and / or casein-containing,
Is adjusted to 8 or more, preferably 10 or more, and folic acid and casein are dissolved.
To 5 or less, preferably 4 or less, and coprecipitate folic acid and casein. As a method of preparing an alkaline solution of folic acid and casein and / or a casein-containing substance, folic acid and casein and / or a casein-containing substance are individually dissolved or dispersed in an alkaline solution or water, and an alkaline aqueous solution is added. Then pH
May be 8 or more to dissolve folic acid and casein,
Further, an alkaline aqueous solution may be added to a mixture of folic acid and casein and / or a casein-containing substance to dissolve the mixture. The total concentration of folic acid and casein in the prepared alkaline solution is not particularly limited, but is usually about 1 to 15% by weight.

【0011】ここで用いられるアルカリは、葉酸とカゼ
インの両方を溶解するものであれば特に制限はなく、好
ましい例として水酸化ナトリウム、水酸化カリウムのよ
うなアルカリ金属水酸化物及びアルカリ土類金属水酸化
物、並びに炭酸ナトリウムのようなアルカリ金属炭酸塩
を挙げることができる。また、用いられる酸としては、
特に制限はなく、塩酸、硫酸等の無機酸、クエン酸、乳
酸、酢酸等の有機酸を好ましく用いることができ、有機
酸は化学合成品、微生物発酵等により調製された天然の
酸の双方とも使用することができる。
The alkali used here is not particularly limited as long as it dissolves both folic acid and casein. Preferred examples thereof include alkali metal hydroxides such as sodium hydroxide and potassium hydroxide, and alkaline earth metals. Hydroxides, as well as alkali metal carbonates such as sodium carbonate. Also, as the acid used,
There is no particular limitation, and inorganic acids such as hydrochloric acid and sulfuric acid, and organic acids such as citric acid, lactic acid and acetic acid can be preferably used.The organic acids are both chemically synthesized products and natural acids prepared by microbial fermentation and the like. Can be used.

【0012】共沈物の製造工程は、好ましくは0℃〜4
0℃で行うことができるが、全て室温で行うことができ
るので、室温で行うことが最も経済的で好ましい。ま
た、沈殿の核となるケイ酸、ケイソウ土、カオリン等の
不活性の担体を添加することもできる。これらの不活性
担体の使用量は、特に限定されないが、酸を加えた後の
混合物の重量を基準として、通常0.1〜10%程度が
好ましい。
The step of producing the coprecipitate is preferably carried out at 0 ° C. to 4 ° C.
Although it can be carried out at 0 ° C., it can be carried out at room temperature, so that it is most economical and preferable to carry out at room temperature. Further, an inert carrier such as silicic acid, diatomaceous earth, kaolin or the like which serves as a nucleus for precipitation can be added. The use amount of these inert carriers is not particularly limited, but is usually preferably about 0.1 to 10% based on the weight of the mixture after adding the acid.

【0013】共沈物を乾燥させるためには適当な方法、
例えば噴霧乾燥法や、ろ過、遠心分離等の方法により沈
殿物を取出した後、常圧又は減圧下で加熱乾燥する方法
等を採用することができる。
Suitable methods for drying the coprecipitate include:
For example, a method in which a precipitate is taken out by a method such as a spray drying method, filtration, or centrifugal separation and then heated and dried under normal pressure or reduced pressure can be employed.

【0014】本発明の葉酸製剤は、上記した共沈物のみ
から成っていてもよいし、常法により、粉末化、顆粒
化、錠剤化、丸剤化等、経口投与に適した剤形に調製す
ることもでき、また、必要に応じて、着色剤、矯味剤、
矯臭剤、賦形剤等の適当な添加剤を含んでいてもよい。
The folate preparation of the present invention may consist of only the above-mentioned coprecipitate, or may be made into a dosage form suitable for oral administration, such as powdering, granulating, tableting, and pilling, by a conventional method. It can also be prepared, and if necessary, a coloring agent, a flavoring agent,
Suitable additives such as a flavoring agent, an excipient and the like may be included.

【0015】本発明の葉酸製剤は、溶解性、吸収性に優
れるとともに保存安定性が高く、流動性も良く各種粉末
薬剤との混合性に優れ、飼料や食品の添加剤として有用
である。家畜やペットの飼料の添加剤として用いる場
合、本発明の葉酸製剤の配合量は特に限定されず、家畜
やペットの種類や状態により異なるが、通常、葉酸量と
して、家畜又はペットの体重1kg、1日当りの摂取量
が1μg〜250μg程度になる量配合することが好ま
しい。
The folic acid preparation of the present invention is excellent in solubility and absorbability, has high storage stability, has good fluidity, is excellent in mixing with various powdered drugs, and is useful as an additive for feed and food. When used as an additive for livestock or pet feed, the amount of the folic acid preparation of the present invention is not particularly limited, and varies depending on the type and condition of the livestock and pets. It is preferable to mix the amount so that the daily intake is about 1 μg to 250 μg.

【0016】[0016]

【実施例】以下、本発明を実施例に基づきさらに具体的
に説明する。もっとも、本発明は下記実施例に限定され
るものではない。
The present invention will be described more specifically below with reference to examples. However, the present invention is not limited to the following examples.

【0017】実施例1 葉酸1gとカゼイン99gの混合物を水1500mlに
分散させた液に、約1Nの水酸化ナトリウム水溶液20
0mlを添加してpHを約12とし、葉酸とカゼインを
溶解した後、約1Nの塩酸溶液220mlを加えてpH
を約3とし、葉酸とカゼインを共沈させた。次に沈殿物
をろ過、乾燥し、葉酸−カゼイン共沈物約98gを得
た。得られた共沈物中で、葉酸は実質的に全量が非結晶
状態であった。
Example 1 A solution of a mixture of 1 g of folic acid and 99 g of casein in 1500 ml of water was added to a solution of about 1N aqueous sodium hydroxide solution.
0 ml was added to adjust the pH to about 12. After dissolving folic acid and casein, about 1N hydrochloric acid solution (220 ml) was added to adjust the pH to about 12.
Was adjusted to about 3, and folic acid and casein were coprecipitated. Next, the precipitate was filtered and dried to obtain about 98 g of folic acid-casein coprecipitate. In the obtained coprecipitate, substantially all folic acid was in an amorphous state.

【0018】実施例2 葉酸2gとカゼイン98gの混合物を水1500mlに
分散させた液に、約1Mの水酸化カリウム水溶液180
mlを添加し、葉酸とカゼインを溶解した後、約1Nの
塩酸溶液210mlを加え、葉酸とカゼインを共沈させ
た。次に沈殿物をろ過、乾燥し、葉酸−カゼイン共沈物
約95gを得た。得られた共沈物中で、葉酸は実質的に
全量が非結晶状態であった。
Example 2 A liquid obtained by dispersing a mixture of 2 g of folic acid and 98 g of casein in 1500 ml of water was mixed with about 1 M aqueous potassium hydroxide solution 180
After adding f.l. ml to dissolve folic acid and casein, about 1N hydrochloric acid solution (210 ml) was added to coprecipitate folic acid and casein. Next, the precipitate was filtered and dried to obtain about 95 g of a folic acid-casein coprecipitate. In the obtained coprecipitate, substantially all folic acid was in an amorphous state.

【0019】実施例3 葉酸2gとカゼイン98gの混合物を水1500mlに
分散させた液に、約1Mの炭酸ナトリウム水溶液100
0mlを添加し、葉酸とカゼインを溶解した後、約1N
の塩酸溶液1000mlを加え、葉酸とカゼインを共沈
させた。次に沈殿物をろ過、乾燥し、葉酸−カゼイン共
沈物約99gを得た。得られた共沈物中で、葉酸は実質
的に全量が非結晶状態であった。
EXAMPLE 3 A solution prepared by dispersing a mixture of 2 g of folic acid and 98 g of casein in 1500 ml of water was mixed with about 1 M aqueous sodium carbonate solution.
After dissolving folic acid and casein, add about 1N
Was added, and folic acid and casein were co-precipitated. Next, the precipitate was filtered and dried to obtain about 99 g of a folate-casein coprecipitate. In the obtained coprecipitate, substantially all folic acid was in an amorphous state.

【0020】実施例4 脱脂粉乳99gを水1500mlに分散させた液に、葉
酸1gを約1Nの水酸化ナトリウム水溶液20mlに溶
解した液を加え、さらに約1Nの水酸化ナトリウム溶液
180mlを添加し、葉酸とカゼインを溶解した後、約
1Nの塩酸溶液220mlを加え、葉酸とカゼインを共
沈させた。次に沈殿物をろ過、乾燥し、葉酸−カゼイン
共沈物約40gを得た。得られた共沈物中で、葉酸は実
質的に全量が非結晶状態であった。
Example 4 To a liquid obtained by dispersing 99 g of skim milk powder in 1500 ml of water was added a solution obtained by dissolving 1 g of folic acid in 20 ml of an about 1 N aqueous sodium hydroxide solution, and further added 180 ml of an about 1 N sodium hydroxide solution. After dissolving folic acid and casein, about 1N hydrochloric acid solution (220 ml) was added to coprecipitate folic acid and casein. Next, the precipitate was filtered and dried to obtain about 40 g of a folate-casein coprecipitate. In the obtained coprecipitate, substantially all folic acid was in an amorphous state.

【0021】実施例5 葉酸2gとカゼイン98gの混合物を水1500mlに
分散させた液に、約1Nの水酸化ナトリウム水溶液20
0mlを添加し、葉酸とカゼインを溶解した後、発酵乳
酸水溶液350mlを加え、葉酸とカゼインを共沈させ
た。次に沈殿物をろ過、乾燥し、葉酸−カゼイン共沈物
約97gを得た。得られた共沈物中で、葉酸は実質的に
全量が非結晶状態であった。
Example 5 A solution prepared by dispersing a mixture of 2 g of folic acid and 98 g of casein in 1500 ml of water was added to a solution of about 1N aqueous sodium hydroxide solution.
After 0 ml was added to dissolve folic acid and casein, 350 ml of an aqueous fermented lactic acid solution was added to coprecipitate folic acid and casein. Next, the precipitate was filtered and dried to obtain about 97 g of a folate-casein coprecipitate. In the obtained coprecipitate, substantially all folic acid was in an amorphous state.

【0022】実施例6 ヨーグルト999gに、葉酸1gを約1Nの水酸化ナト
リウム水溶液20mlに溶解した液を加え、さらに約1
Nの水酸化ナトリウム水溶液180mlを添加し、葉酸
とカゼインを溶解した後、約1Nの塩酸溶液220ml
を加え、葉酸とカゼインを共沈させた。次に沈殿物をろ
過、乾燥し、葉酸−カゼイン共沈物約45gを得た。得
られた共沈物中で、葉酸は実質的に全量が非結晶状態で
あった。
Example 6 To 999 g of yogurt, a solution prepared by dissolving 1 g of folic acid in 20 ml of a 1N aqueous sodium hydroxide solution was added.
After adding 180 ml of an N aqueous sodium hydroxide solution to dissolve folic acid and casein, 220 ml of a 1N hydrochloric acid solution was added.
Was added to co-precipitate folic acid and casein. Next, the precipitate was filtered and dried to obtain about 45 g of a folic acid-casein coprecipitate. In the obtained coprecipitate, substantially all folic acid was in an amorphous state.

【0023】実施例7 葉酸5gとカゼイン95gの混合物を水1500mlに
分散させた液に、約1Nの水酸化ナトリウム水溶液21
0mlを添加し、葉酸とカゼインを溶解した後、約1N
の塩酸溶液240mlを加え、葉酸とカゼインを共沈さ
せた。次に沈殿物をろ過、乾燥し、葉酸−カゼイン共沈
物約97gを得た。得られた共沈物中で、葉酸は実質的
に全量が非結晶状態であった。
Example 7 A liquid obtained by dispersing a mixture of 5 g of folic acid and 95 g of casein in 1500 ml of water was mixed with about 1N aqueous sodium hydroxide solution 21.
After dissolving folic acid and casein, add about 1N
Was added, and folic acid and casein were coprecipitated. Next, the precipitate was filtered and dried to obtain about 97 g of a folate-casein coprecipitate. In the obtained coprecipitate, substantially all folic acid was in an amorphous state.

【0024】実施例8 葉酸20gとカゼイン80gの混合物を水1500ml
に分散させた液に、約1Mの水酸化カリウム水溶液25
0mlを添加し、葉酸とカゼインを溶解した後、約1N
の塩酸溶液260mlを加え、葉酸とカゼインを共沈さ
せた。次に沈殿物をろ過、乾燥し、葉酸−カゼイン共沈
物約96gを得た。得られた共沈物中で、葉酸は実質的
に全量が非結晶状態であった。
Example 8 A mixture of 20 g of folic acid and 80 g of casein was mixed with 1500 ml of water.
Is added to an aqueous solution of about 1 M potassium hydroxide 25
After dissolving folic acid and casein, add about 1N
Was added, and folic acid and casein were coprecipitated. Next, the precipitate was filtered and dried to obtain about 96 g of a folate-casein coprecipitate. In the obtained coprecipitate, substantially all folic acid was in an amorphous state.

【0025】実施例9 実施例1及び実施例7で得られた共沈物と、比較例とし
てこれらの共沈物の製造に使用した葉酸原末を添加した
ビタミン・ミネラル混合物中の葉酸の安定性を試験し
た。
Example 9 Stability of folic acid in the vitamin-mineral mixture to which the coprecipitates obtained in Examples 1 and 7 were added and, as a comparative example, the raw folic acid powder used for producing these coprecipitates was added Sex was tested.

【0026】(1) 配合割合 各成分の配合割合は、下記表1に示す通りであった。(1) Mixing ratio The mixing ratio of each component was as shown in Table 1 below.

【0027】[0027]

【表1】 [Table 1]

【0028】(2) 安定性試験条件 試料各500gをポリエチレン袋に入れ密封し、温度4
0℃、相対湿度75%条件で保存した。
(2) Stability test conditions 500 g of each sample was put in a polyethylene bag and sealed.
It was stored at 0 ° C. and 75% relative humidity.

【0029】(3) 葉酸の定量法 飼料分析基準註解(第二版)10.17葉酸定量法によ
る(社団法人日本飼料協会発行)。
(3) Determination of folic acid Feed analysis standard comment (second edition) 10.17 Determined by folic acid determination (published by Japan Feed Association).

【0030】(4) 試験結果 保存後の葉酸の残存率(%)を下記表2に示す。(4) Test Results Table 2 below shows the residual ratio (%) of folic acid after storage.

【0031】[0031]

【表2】 [Table 2]

【0032】以上の結果から、本発明の葉酸製剤は、比
較例の葉酸原末に比べ保存安定性がはるかに優れている
ことがわかる。
From the above results, it can be seen that the folic acid preparation of the present invention has much better storage stability than the folic acid bulk powder of the comparative example.

【0033】実施例10 実施例1及び実施例7で得られた共沈物と、比較例とし
てこれらの共沈物の製造に使用した葉酸原末の人工胃液
での溶出率を試験した。
Example 10 The dissolution rates of the coprecipitates obtained in Examples 1 and 7 and the raw folic acid powder used for producing these coprecipitates in artificial gastric juice as a comparative example were tested.

【0034】(1) 溶解性試験条件 日本薬局方(第十三改正)崩壊試験法の試験液第一液に
100mlに試料3gを加え、20℃の恒温槽の中で一
時間振盪した後、懸濁液を遠心分離(10000rp
m、30分間)し、上澄液中の葉酸含量を測定した。
(1) Solubility test conditions A 3 g sample was added to 100 ml of the test solution of the Japanese Pharmacopoeia (13th revision) disintegration test method, and after shaking for 1 hour in a thermostat at 20 ° C. The suspension is centrifuged (10000 rpm
m, 30 minutes), and the folic acid content in the supernatant was measured.

【0035】(2) 葉酸の定量法 飼料分析基準註解(第二版)10.17葉酸定量法によ
る(社団法人日本飼料協会発行)。
(2) Determination of folic acid Feed analysis standard comment (second edition) 10.17 Determined by folic acid (published by Japan Feed Association).

【0036】(3) 試験結果 各例における葉酸の溶出量を下記表3に示す。(3) Test results Table 3 below shows the amount of folic acid eluted in each case.

【0037】[0037]

【表3】 [Table 3]

【0038】以上の結果から、本発明の葉酸製剤は、溶
出性が極めて良好であるため葉酸の吸収率が高く、バイ
オアベイラビリティが優れていることが明らかである。
From the above results, it is clear that the folic acid preparation of the present invention has a very good dissolution property, so that the folic acid absorption rate is high and the bioavailability is excellent.

【0039】実施例11 実施例1で得られた共沈物と、比較例としてこの共沈物
の製造に使用した葉酸原末をブタに経口投与し、血中濃
度の推移を調べた。
Example 11 Pigs were orally administered the coprecipitate obtained in Example 1 and, as a comparative example, the raw folic acid powder used for producing this coprecipitate, and the change in blood concentration was examined.

【0040】(1) 血中濃度の試験条件 一日絶食させたブタ(体重85〜100kg)3頭に各
試料を約300gの配合飼料と混合して経口投与し、投
与後1時間、2時間、4時間、6時間、8時間、10時
間及び24時間後について血漿中の総葉酸濃度をマイク
ロバイオアッセイ法により測定した。
(1) Test Conditions for Blood Concentration Three pigs (body weight: 85 to 100 kg) which had been fasted for one day were orally administered with each sample mixed with about 300 g of a mixed feed for 1 hour and 2 hours after administration. The total folate concentration in plasma was measured by microbioassay after 4, 6, 8, 10 and 24 hours.

【0041】(2) 葉酸の定量法 Lactobacillus casei ATCC7469を用いたマイクロバイオ
アッセイ法によった。
(2) Determination of folic acid A microbioassay method using Lactobacillus casei ATCC7469 was used.

【0042】(3) 試験結果 結果を図1及び図2に示す。これらの結果から、最高血
漿中濃度、血漿中濃度曲線下面積ともに、本発明の葉酸
製剤は、対照の葉酸製剤よりもはるかに優れていること
が判明した。すなわち、葉酸とカゼインを共沈し、葉酸
をカゼイン中に実質的に非結晶状態に存在させることに
より、溶解性及び血中への移行性が著しく改善され、バ
イオアベイラビリティが大きく向上することが明かとな
った。
(3) Test Results The results are shown in FIGS. 1 and 2. From these results, it was found that the folic acid preparation of the present invention was far superior to the control folic acid preparation in both the maximum plasma concentration and the area under the plasma concentration curve. That is, by coprecipitating folic acid and casein and causing folic acid to be present in the casein in a substantially non-crystalline state, the solubility and translocation to blood are significantly improved, and the bioavailability is significantly improved. It was ok.

【0043】[0043]

【発明の効果】本発明によれば、溶解性、吸収性に優れ
るとともに保存安定性が高く、流動性も良く各種粉末薬
剤との混合性に優れ、飼料や食品の添加剤として有用な
葉酸製剤が提供された。
Industrial Applicability According to the present invention, folic acid preparations having excellent solubility and absorbability, high storage stability, good flowability, excellent mixing with various powdered drugs, and useful as additives for feeds and foods. Was provided.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本発明の実施例の葉酸製剤又は対照として葉酸
原末をブタに経口投与した場合の血漿中総葉酸濃度の経
時的変化を示す図である。
BRIEF DESCRIPTION OF DRAWINGS FIG. 1 is a graph showing changes over time in plasma total folate concentration when a folic acid preparation of the example of the present invention or an original folic acid powder as a control is orally administered to pigs.

【図2】図1に示す血漿中総葉酸濃度曲線の下側の面積
を比較して示す図である。
FIG. 2 is a diagram comparing the areas under the plasma total folate concentration curve shown in FIG. 1;

フロントページの続き (58)調査した分野(Int.Cl.7,DB名) A23K 1/16 301 A23K 1/16 303 A61K 31/505 A61K 47/42 BIOSIS(DIALOG) CA(STN) JICSTファイル(JOIS) REGISTRY(STN) WPIDS(STN)Continuation of the front page (58) Fields surveyed (Int.Cl. 7 , DB name) A23K 1/16 301 A23K 1/16 303 A61K 31/505 A61K 47/42 BIOSIS (DIALOG) CA (STN) JICST file (JOIS ) REGISTRY (STN) WPIDS (STN)

Claims (6)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 葉酸と、カゼイン及び/又はカゼイン含
有物の共沈物を含む葉酸製剤。
1. A folate preparation comprising folic acid and a co-precipitate of casein and / or casein-containing substances.
【請求項2】 前記共沈物は、葉酸と、カゼイン及び/
又はカゼイン含有物のアルカリ性溶液に酸を添加し、葉
酸とカゼインを共沈させることにより製造されたもので
ある請求項1記載の葉酸製剤。
2. The coprecipitate comprises folic acid, casein and / or
The folate preparation according to claim 1, which is produced by adding an acid to an alkaline solution of a casein-containing substance and coprecipitating folate and casein.
【請求項3】 前記共沈物中の葉酸とカゼインとの重量
比が1:1ないし1:1000である請求項1又は2記
載の葉酸製剤。
3. The folate preparation according to claim 1, wherein the weight ratio of folic acid to casein in the coprecipitate is from 1: 1 to 1: 1000.
【請求項4】 前記カゼイン含有物は、カゼインナトリ
ウム、牛乳、脱脂粉乳、発酵乳又はヨーグルトである請
求項1ないし3のいずれか1項に記載の葉酸製剤。
4. The folate preparation according to claim 1, wherein the casein-containing substance is sodium caseinate, milk, skim milk powder, fermented milk, or yogurt.
【請求項5】 葉酸と、カゼイン及び/又はカゼイン含
有物を少なくとも含むアルカリ性溶液に酸を添加し、葉
酸とカゼインを共沈させる工程を含む、請求項1記載の
葉酸製剤の製造方法。
5. The method for producing a folate preparation according to claim 1, comprising a step of adding an acid to an alkaline solution containing at least folate and casein and / or a casein-containing substance to coprecipitate folate and casein.
【請求項6】 請求項1ないし4のいずれか1項に記載
の葉酸製剤を含む飼料。
6. A feed containing the folic acid preparation according to claim 1.
JP10039582A 1998-02-05 1998-02-05 Easy-absorbable folic acid preparation, production method thereof and feed containing the same Expired - Fee Related JP3037654B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10039582A JP3037654B2 (en) 1998-02-05 1998-02-05 Easy-absorbable folic acid preparation, production method thereof and feed containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10039582A JP3037654B2 (en) 1998-02-05 1998-02-05 Easy-absorbable folic acid preparation, production method thereof and feed containing the same

Publications (2)

Publication Number Publication Date
JPH11221028A JPH11221028A (en) 1999-08-17
JP3037654B2 true JP3037654B2 (en) 2000-04-24

Family

ID=12557098

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10039582A Expired - Fee Related JP3037654B2 (en) 1998-02-05 1998-02-05 Easy-absorbable folic acid preparation, production method thereof and feed containing the same

Country Status (1)

Country Link
JP (1) JP3037654B2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080111033A (en) * 2006-03-29 2008-12-22 후지필름 가부시키가이샤 Casein nanoparticle
JP2008201767A (en) * 2007-01-24 2008-09-04 Fujifilm Corp Composition for hair
US20080175807A1 (en) 2007-01-24 2008-07-24 Fujifilm Corporation Composition for hair
JP2008255020A (en) * 2007-04-02 2008-10-23 Fujifilm Corp Antiaging skin care preparation
JP2015030690A (en) * 2013-08-01 2015-02-16 東洋精糖株式会社 Composition with improved bioabsorbability of pteridine derivative and bioabsorbency promoter

Also Published As

Publication number Publication date
JPH11221028A (en) 1999-08-17

Similar Documents

Publication Publication Date Title
TWI465239B (en) Polynuclear iron(iii)-based phosphate adsorbent, composition and solid or semi-solid dosage form comprising the same, its preparing process and use thereof and process for preparing gamma-iron(iii) oxide-hydroxide
NZ539277A (en) Pharmaceutical product comprising a therapeutically active agent together with a pharmaceutical excipient for use with poorly water-soluble therapeutically active agents
EP0862915B1 (en) Antibacterial composition for oral administration
HUE035013T2 (en) Delayed release, oral dosage compositions that contain amorphous cddo-me
JP6339089B2 (en) Oral suspension containing amorphous tolvaptan
JP3518601B2 (en) Pharmaceutical composition based on ebastime or an analogue thereof
JP5757493B1 (en) Solid composition for oral iron supplementation and method for producing the same
US20060057252A1 (en) Composition containing calcium pantothenate and vitamin
IE54572B1 (en) Pharmaceutically active succinylated proteins comprising iron
HU229936B1 (en) Particles coated with granulated crystalline ibuprofen
CN115837012A (en) Amlodipine dry suspension and preparation method thereof
JP3037654B2 (en) Easy-absorbable folic acid preparation, production method thereof and feed containing the same
JPH0717866A (en) Medicinal composition
KR100888519B1 (en) Pediatric Formulation of Gatifloxacin
JPH07267850A (en) Medicine composition prevented in unpleasant taste and method for producing the same
CN102481288A (en) Pharmaceutical composition of temozolomide comprising amino acid stabilizer and preparation method thereof
CN104788421A (en) Erdosteine compound for treating respiratory tract inflammation and preparation method of erdosteine compound
EP3534915B1 (en) Gamma-polyglutamic acid and zinc compositions
JP5980449B2 (en) Solid dispersion containing amorphous cilostazol
JP2003319760A (en) Zinc-containing substance having anti-obesity function
JPH0753581A (en) Production of crystalline magnesium salt of l-ascorbic acid-2-phosphoric acid ester
JP4387379B2 (en) Calcium reinforcement
JPH0347124A (en) Oral absorption drug
JP2831135B2 (en) Antibacterial composition for oral administration
JP3944273B2 (en) Calcium reinforcement

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20000118

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090225

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100225

Year of fee payment: 10

LAPS Cancellation because of no payment of annual fees